期刊文献+

血清白细胞介素-18与冠心病的相关性研究 被引量:1

Relationship Between Serum Interleukin-18 and Coronary Heart Disease
暂未订购
导出
摘要 目的:探讨血清白细胞介素-18水平(IL-18)与不同类型冠心病患者及其他心血管病危险因素的关系。方法:分别测定各研究组的血清IL-18水平,比较各组间的差异及与其他心血管病危险因素的关系。结果:冠心病患者血清IL-18水平明显高于对照组,其中急性心梗和不稳定心绞痛组IL-18与稳定型心绞痛组及对照组比较有差异性(P<0.05)。IL-18冠心病的并发症之间存在一定的相关性。结论:IL-18水平是反映冠脉粥样病变的炎症反应的主要指标之一,也是预示急性冠脉事件发生的标志。 Objective: To investigate the relationship between interleukin- 18 (IL- 18) and coronary heart disease and other cardiovascular risk factors. Methods:The level of serum IL - 18 in groups were measured and compared. The relationship between IL- 18 and other cardiovascular risk factors was analyzed. Results: Compared with control group, the level of IL - 18 in patients with coronary heart disease was higher, specially in acute myocardial infarction group and unstable angina group. The difference was significant (P〈 0.05). IL- 18 was related to complications of coronary heart disease. Conclusion :The level of IL- 18 is one of major indictors inflecting inflammation in coronary atherosclerotic lesion. It also predict the occurance of acute coronary events.
出处 《内蒙古医学杂志》 2005年第9期778-781,共4页 Inner Mongolia Medical Journal
关键词 白细胞介素-18 冠心病 Interleukin - 18( IL - 18) Coronary heart disease
  • 相关文献

参考文献6

  • 1孙文长.白细胞介素18研究进展[J].国外医学(临床生物化学与检验学分册),2000,21(2):57-59. 被引量:31
  • 2Ziad M, Anne C, Alexandra S, et al. Expression of lnterleukin - 18 in Human Atherosclerotic Plaques and Relation to Plaque Instability[J].Circulation ,2001, 104 : 1598.
  • 3Ziad M,Henry P,Fressonnet R,et al.Inereased pfasma concentrations of interleukin-18 in acute coronary sondromes[J].Heart,2002.88:467.
  • 4Yukihiro S, Tsugiyasu K, Toru T, et al. Interleukin - 18 in in myocardial infarction[ J ]. Heart, 2000,84:668.
  • 5Stefan B,Laurence T,Christoph B,et al.Interleukin-18 Isa Strong Prdietor of Cardiovascular Death in Stable and Unstable Angina[J].Cireulation,2002.106:24.
  • 6Naito Y,Tsujino T,Fujioka Y,et al.Inereased circulation interleukin-18 in patients with congestive heart failure[J].Heart.2002.88:296.

二级参考文献15

  • 1MicallefMJ,YoshidaK,KawaiS,etal.CancerImmunolImmunother,1997,43(2):361~367
  • 2TsutsuiH,MatsuiK,KawadaN,etal.JImmunol,1997,159(8):3961-3967
  • 3YoshimotoT,Okamura,H,TagawaY,etal.ProcNatlAcadSciUSA,1997,94(8):3948-3953
  • 4HorwoodNJ,UdagawaN,Elliott,J,etal.JClinInvest.1998,101(3):595-603
  • 5RotheH,JenkinsNA,CopelandNG,etal.JClinInvest,1997,99(3):469-474
  • 6KobayashiK,NakataN,KaiM,etal.ClinImmunolImmunopathol,1997,85(1):112~116
  • 7ZhangT,KawakamiK,QureshiMH,etal.InfectImmun,1997,65(9):3594-3599
  • 8OkamuraH,TsutsuiH,KomatsuT,etal.Nature,1995,378(6552):88-91
  • 9UshioS,NambaM,OkuraT,etal.JImmunology,1996,156(11):4274-4279
  • 10GuY,KuidaK,TsutsuiH,etal.Science,1997,275(5297):206-209

共引文献30

同被引文献11

  • 1张燕,黎莉,张运,谭红伟,马志勇,王颖,李静,朱圆圆.冠心病心绞痛患者白细胞介素18水平的变化[J].中国动脉硬化杂志,2005,13(4):500-502. 被引量:5
  • 2Blankenberg S, Luc G, Ducimetiere P, et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation, 2003, 108(20) : 2453-2459.
  • 3Tsutsui H, Matsui K, Okamura H, et al. Pathophysiological roles of interleukin-18 in inflammatory liver diseases, Immunol Rev,2000, 174: 192-209.
  • 4Mallat Z. Corbaz A, Scoazec A, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability.Circulation. 2001, 104(14): 1598-1603.
  • 5Mallat Z, Henry P, Fressonnet R, et al. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart,2002. 88(5): 467-469.
  • 6Whitman SC,Ravisankar P,Daugherty A.Interleukin-18 enhances atherosclerosis in apolipoprotein E (-/-)mice through release of interferon-gamma. Circ Res, 2002, 90(2) : E34-E38.
  • 7Mallat Z, Corbaz A, Scoazec A, et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res, 2001, 89(7): E41-E45.
  • 8Yamaoka-Tojo M, Tojo T, Inomata T, et al. Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J Card Fail, 2002, 8(1): 21-27.
  • 9Pomerantz BJ, Reznikov LL, Harken AH, et al. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1 beta. Proc Natl Acad Sci USA, 2001, 98(5) :2871-2876.
  • 10Woldbaek PR, Sande JB, Stromme TA, et al. Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice.Am J Physiol Heart Circ Physiol, 2005, 289(2) : H708-H714.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部